Transl Clin Pharmacol.  2016 Dec;24(4):153-156. 10.12793/tcp.2016.24.4.153.

Pitfalls in the calculation of hemodialysis clearance and in the assessment of dialysis efficacy

• Atkinson A

• KMID: 2413835
• DOI: http://doi.org/10.12793/tcp.2016.24.4.153

Abstract

The therapeutic technique of hemodialysis and the concept of clearance have both followed a long but instructive course of development. In addition, it recently has been shown that physiological changes occurring during hemodialysis have important clinical consequences both in the treatment of drug toxicity and in the selection of appropriate replacement doses of therapeutic drugs. Two major approaches for calculating hemodialysis clearance are currently used. The first approach, termed the recovery method is the "gold standard" that is recommended for use in the current US FDA draft guidance on the conduct of pharmacokinetic studies in patients with impaired renal function. The second approach, termed the A-V difference method, is used more commonly. Unfortunately, this method results in erroneous plasma clearance estimates when improper values for dialyzer flow are chosen. This constitutes a major pitfall that should be avoided in future studies.

Keyword

Hemodialysis; Hemodialytic clearance; Drug toxicity; Drug replacement doses; Recovery method; A-V Difference method

MeSH Terms

Dialysis*
Drug-Related Side Effects and Adverse Reactions
Humans
Methods
Plasma
Renal Dialysis*

Reference

1.Able JJ., Rowntree LG., Turner BB. On the removal of diffusible substances from the circulating blood of living animals by dialysis. J Pharmacol Exp Ther. 1914. 5:275–317.

2.Haas G. Veersuche der blutauswaschung am lebenden mit hilfe der dialysis. Klin Wochenschr. 1925. 4:13–14.

3.Haas G. Über blutwashung. Klin Wochenschr. 1928. 7:1356–1362.

4.Wizemann V. Hemodialysis: 70 years. Clin Investig. 1994. 72:720–721.

5.Kolff WJ., Berk HTJ. The artificial kidney: a dialyzer with a great area. Acta Med Scand. 1944. 117:121–134.

6.Addis T., Watanabe CK. A method for the measurement of the urea-excreting function of the kidneys. J Biol Chem. 1916. 28:251–259.

7.Möller E., McIntosh JF., Van Slyke DD. Studies of urea excretion. II. Relationship between urine volume and the rate of urea excretion by normal adults. Definition and calculation of the maximum and standard blood urea clearances. J Clin Invest. 1928. 6:427–465.

8.Fick A. Über die measung des blutquantums in der herzventrickeln. Sitzun-gen der phys-med gesellsch zu Wûrzburg. 1870. 16:XIV. Sitzung am 8 Juli 1870.

9.Wolf AV., Remp DG., Kiley JE., Currie GD. Artificial kidney function: kinetics of hemodialysis. J Clin Invest. 1951. 30:1062–1070.

10.Doolan PK., Walsh WP., Kyle LH., Wishinsky H. Acetylsalicylic acid intoxication. A. Proposed method of treatment. JAMA. 1951. 146:105–106.

11.Cutler RE., Forland SC., St John Hammond PG., Evans JR. Extracorporeal removal of drugs and poisons by hemodialysis and hemoperfusion. Ann Rev Pharmacol Toxicol. 1987. 27:169–191.

12.Takki S., Gambertoglio JG., Honda DH., Tozer TN. Pharmacokinetic evaluation of hemodialysis in acute drug overdose. J Pharmacokinet Biopharm. 1978. 6:427–442.

13.Levy G. Pharmacokinetics in renal disease. Am J Med. 1977. 62:461–465.

14.CDER. Draft Guidance for Industry. Pharmacokinetics in patients with impaired renal function - study design, data analysis, and impact on dosing and labeling.http://www.fda.gov/downloads/Drugs/.../Guidances/UCM204959.pdfAccessed10October2016.

15.Stec GP., Atkinson AJ Jr., Nevin MJ., Thenot JP., Ruo TI., Gibson TP, et al. N-Acetylprocainamide pharmacokinetics in functionally anephric patients before and after perturbation by hemodialysis. Clin Pharmacol Ther. 1979. 26:618–628.

16.Lee CS., Marbury TC., Benet LZ. Clearance calculations in hemodialysis: Application to blood, plasma, and dialysate measurements for ethambutol. J Pharmacokinet Biopharm. 1980. 8:69–81.

17.Bowsher DJ., Krejcie TC., Avram MJ., Chow MJ., Del Greco F., Atkinson AJ. Reduction in slow intercompartmental clearance of urea during dialysis. J Lab Clin Med. 1985. 105:489–497.

18.Atkinson AJ Jr., Krumlovsky FA., Huang CM., del Greco F. Hemodialysis for severe procainamide toxicity: clinical and pharmacokinetic observations. Clin Pharmacol Ther. 1976. 20:585–592.